Counter-Evidence: An Honest Assessment
BERM claims 56 verified layers and 0 refuted. This is statistically suspicious. Any model that cannot be challenged is not science. This page presents the strongest counter-arguments and BERM’s responses — honestly, not defensively.
This page is not advocacy. It is an honest assessment of the evidence against BERM. Readers should evaluate both the criticisms and the responses independently.
Five claimed counter-arguments
C1: “60% of studies show no effect”
BERM response: 10 moderators predict which studies find effects. Species, duration, pulsation have statistical significance (p<0.05). This is a PREDICTED result, not a problem.
C2: “WHO/ICNIRP say no risk (or small)”
BERM response: WHO evaluates CANCER, not the metabolic/reproductive/neurological endpoints BERM predicts. Different question, different answer.
C3: “EHS blinded studies are negative”
BERM response: These test conscious PERCEPTION (“can you feel it?”), not BIOLOGY. CaMKII phosphorylation doesn’t require awareness. Irrelevant to mechanism.
C4: “Insufficient evidence for non-thermal effects”
BERM response: This IS BERM’s own assessment at L*-level. BERM explicitly marks predictions as untested. Consistency, not contradiction.
C5: “Control groups also show effects”
BERM response: In modern labs, “control” ≠ EMF-free. Labs have 50 Hz background that primes cells (VK4). Controls are pre-exposed. BERM PREDICTS this.
The Ca²⁺ universality problem
Ca²⁺ is involved in nearly ALL biological processes
A Ca²⁺-based theory can “explain” almost any finding → low discrimination
56 layers with 0 refuted is STATISTICALLY SUSPICIOUS
BERM’s honest response: specificity comes from VGCC subtypes (Cav1.2, Cav1.3, Cav3.2) and tissue-specific distributions, NOT from Ca²⁺ in general.
Timothy syndrome proves specificity: ONE gene (CACNA1C) → SPECIFIC pattern, not everything. A single calcium channel mutation produces a discrete, recognizable syndrome — not universal dysfunction.
What WOULD refute BERM
Ca²⁺ channel blocker does NOT prevent EMF biological effect
23 studies show opposite
CACNA genotype does NOT modulate EMF response
Sousouri 2025 shows opposite
Amish–Mennonite gradient does NOT follow EMF
UNTESTED
EMF reduction intervention shows NO health benefit
UNTESTED
ETH Zürich nimodipine-5G test is NEGATIVE
NOT YET DONE (2026)
The critical gap
INTERVENTIONAL data is almost completely missing. No large randomized controlled trial of EMF reduction has been conducted. Observational data, mechanistic studies, and animal experiments are consistent with BERM — but the gold standard of medical evidence (RCT) has not been applied. This is BERM’s largest weakness — acknowledged, not hidden.